summary,summary_detail,id,guidislink,links,url,date,published_parsed,title,title_detail,ticker,source,text,Year,Month,Day,Weekday,text_length,word_count,title_length,title_word_count
"A report says China ordered a halt to Boeing jet deliveries as part of the escalating trade war with the U.S., while Tesla’s stock chart forms a ‘death cross.’ Earnings are expected Tuesday from Bank of America, Citigroup, and Johnson & Johnson.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'A report says China ordered a halt to Boeing jet deliveries as part of the escalating trade war with the U.S., while Tesla’s stock chart forms a ‘death cross.’ Earnings are expected Tuesday from Bank of America, Citigroup, and Johnson & Johnson.'}",4acd1581-8487-308e-9a2a-48ddeb05703c,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/m/4acd1581-8487-308e-9a2a-48ddeb05703c/these-stocks-are-moving-the.html?.tsrc=rss'}]",https://finance.yahoo.com/m/4acd1581-8487-308e-9a2a-48ddeb05703c/these-stocks-are-moving-the.html?.tsrc=rss,2025-04-15 09:16:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=15, tm_hour=9, tm_min=16, tm_sec=0, tm_wday=1, tm_yday=105, tm_isdst=0)","These Stocks Are Moving the Most Today: Boeing, Tesla, Netflix, Bank of America, J&J, Allegro MicroSystems, and More","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'These Stocks Are Moving the Most Today: Boeing, Tesla, Netflix, Bank of America, J&J, Allegro MicroSystems, and More'}",JNJ,Yahoo Finance,"These Stocks Are Moving the Most Today: Boeing, Tesla, Netflix, Bank of America, J&J, Allegro MicroSystems, and More A report says China ordered a halt to Boeing jet deliveries as part of the escalating trade war with the U.S., while Tesla’s stock chart forms a ‘death cross.’ Earnings are expected Tuesday from Bank of America, Citigroup, and Johnson & Johnson.",2025,4,15,1,362,60,116,18
"Yahoo Finance host Josh Lipton highlights what to watch on Tuesday, April 15. Earnings reports are expected from Johnson & Johnson (JNJ), Albertsons (ACI), and United Airlines (UAL), as well as major banks like Bank of America (BAC) and Citi (C). Fresh Federal Reserve commentary is coming as Fed Governor Lisa Cook is set to speak. The deadline to file 2024 federal income tax returns is also on Tuesday. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Yahoo Finance host Josh Lipton highlights what to watch on Tuesday, April 15. Earnings reports are expected from Johnson & Johnson (JNJ), Albertsons (ACI), and United Airlines (UAL), as well as major banks like Bank of America (BAC) and Citi (C). Fresh Federal Reserve commentary is coming as Fed Governor Lisa Cook is set to speak. The deadline to file 2024 federal income tax returns is also on Tuesday. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime\xa0here.'}",0e7e3585-8919-328e-ad0b-a9063c7ebde8,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/video/big-bank-earnings-fed-commentary-230000867.html?.tsrc=rss'}]",https://finance.yahoo.com/video/big-bank-earnings-fed-commentary-230000867.html?.tsrc=rss,2025-04-14 23:00:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=14, tm_hour=23, tm_min=0, tm_sec=0, tm_wday=0, tm_yday=104, tm_isdst=0)","Big Bank earnings, Fed commentary, tax deadline: What to Watch","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Big Bank earnings, Fed commentary, tax deadline: What to Watch'}",JNJ,Yahoo Finance,"Big Bank earnings, Fed commentary, tax deadline: What to Watch Yahoo Finance host Josh Lipton highlights what to watch on Tuesday, April 15. Earnings reports are expected from Johnson & Johnson (JNJ), Albertsons (ACI), and United Airlines (UAL), as well as major banks like Bank of America (BAC) and Citi (C). Fresh Federal Reserve commentary is coming as Fed Governor Lisa Cook is set to speak. The deadline to file 2024 federal income tax returns is also on Tuesday. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",2025,4,14,0,588,98,62,10
"Pfizer (PFE) is ending a late-stage trial of its once-daily GLP-1 pill, Danuglipron, after a participant experienced a liver injury. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination Overtime to break down the details, as well as preview what to watch as Johnson & Johnson (JNJ) prepares to report earnings. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Pfizer (PFE) is ending a late-stage trial of its once-daily GLP-1 pill, Danuglipron, after a participant experienced a liver injury. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination Overtime to break down the details, as well as preview what to watch as Johnson & Johnson (JNJ) prepares to report earnings. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime\xa0here.'}",f88d4467-6707-3e27-b24d-83c4852233e3,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/video/pfizer-hits-setback-obesity-drug-214449466.html?.tsrc=rss'}]",https://finance.yahoo.com/video/pfizer-hits-setback-obesity-drug-214449466.html?.tsrc=rss,2025-04-14 21:44:49,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=14, tm_hour=21, tm_min=44, tm_sec=49, tm_wday=0, tm_yday=104, tm_isdst=0)",Pfizer hits setback in obesity drug race as GLP-1 trial halts,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Pfizer hits setback in obesity drug race as GLP-1 trial halts'}",JNJ,Yahoo Finance,"Pfizer hits setback in obesity drug race as GLP-1 trial halts Pfizer (PFE) is ending a late-stage trial of its once-daily GLP-1 pill, Danuglipron, after a participant experienced a liver injury. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination Overtime to break down the details, as well as preview what to watch as Johnson & Johnson (JNJ) prepares to report earnings. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",2025,4,14,0,510,81,61,11
"Johnson & Johnson  is scheduled to report its  fiscal first-quarter earnings before markets open on Tuesday, but the company has bigger hurdles to clear than meeting Wall Street’s expectations.  While shares have lagged behind the  for the past three years, J&amp;J remains up 6.7% in 2025 versus the broader market’s 8.1% decline.  Part of the appeal is J&amp;J’s resilience in the face of a potential recession.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Johnson & Johnson  is scheduled to report its  fiscal first-quarter earnings before markets open on Tuesday, but the company has bigger hurdles to clear than meeting Wall Street’s expectations.  While shares have lagged behind the  for the past three years, J&amp;J remains up 6.7% in 2025 versus the broader market’s 8.1% decline.  Part of the appeal is J&amp;J’s resilience in the face of a potential recession.'}",cbffbae0-c324-3c1f-8b01-8215d56751a7,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/m/cbffbae0-c324-3c1f-8b01-8215d56751a7/johnson-%26-johnson-is-beating.html?.tsrc=rss'}]",https://finance.yahoo.com/m/cbffbae0-c324-3c1f-8b01-8215d56751a7/johnson-%26-johnson-is-beating.html?.tsrc=rss,2025-04-14 20:44:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=14, tm_hour=20, tm_min=44, tm_sec=0, tm_wday=0, tm_yday=104, tm_isdst=0)",Johnson & Johnson Is Beating the Market. Legal Troubles Continue as Earnings Arrive.,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Johnson & Johnson Is Beating the Market. Legal Troubles Continue as Earnings Arrive.'}",JNJ,Yahoo Finance,"Johnson & Johnson Is Beating the Market. Legal Troubles Continue as Earnings Arrive. Johnson & Johnson  is scheduled to report its  fiscal first-quarter earnings before markets open on Tuesday, but the company has bigger hurdles to clear than meeting Wall Street’s expectations.  While shares have lagged behind the  for the past three years, J&amp;J remains up 6.7% in 2025 versus the broader market’s 8.1% decline.  Part of the appeal is J&amp;J’s resilience in the face of a potential recession.",2025,4,14,0,498,79,84,13
Multinational healthcare company Johnson & Johnson (NYSE:JNJ) will be reporting results tomorrow before market open. Here’s what investors should know.,"{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Multinational healthcare company Johnson & Johnson (NYSE:JNJ) will be reporting results tomorrow before market open. Here’s what investors should know.'}",389dd411-d8bc-3938-822c-da08fba08739,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/johnson-johnson-jnj-reports-earnings-161705076.html?.tsrc=rss'}]",https://finance.yahoo.com/news/johnson-johnson-jnj-reports-earnings-161705076.html?.tsrc=rss,2025-04-14 16:17:05,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=14, tm_hour=16, tm_min=17, tm_sec=5, tm_wday=0, tm_yday=104, tm_isdst=0)",Johnson & Johnson (JNJ) Reports Earnings Tomorrow: What To Expect,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Johnson & Johnson (JNJ) Reports Earnings Tomorrow: What To Expect'}",JNJ,Yahoo Finance,Johnson & Johnson (JNJ) Reports Earnings Tomorrow: What To Expect Multinational healthcare company Johnson & Johnson (NYSE:JNJ) will be reporting results tomorrow before market open. Here’s what investors should know.,2025,4,14,0,217,30,65,10
"We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best dividend-paying stocks. Dividend-paying stocks have consistently attracted investor interest due to their long-term value. CNBC highlights this by examining […]","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best dividend-paying stocks. Dividend-paying stocks have consistently attracted investor interest due to their long-term value. CNBC highlights this by examining […]'}",13b98f58-c394-3930-bb31-50bfb14616d8,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/johnson-johnson-jnj-best-dividend-135058198.html?.tsrc=rss'}]",https://finance.yahoo.com/news/johnson-johnson-jnj-best-dividend-135058198.html?.tsrc=rss,2025-04-14 13:50:58,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=14, tm_hour=13, tm_min=50, tm_sec=58, tm_wday=0, tm_yday=104, tm_isdst=0)",Is Johnson & Johnson (JNJ) the Best Dividend Paying Stock According to Hedge Funds?,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Is Johnson & Johnson (JNJ) the Best Dividend Paying Stock According to Hedge Funds?'}",JNJ,Yahoo Finance,"Is Johnson & Johnson (JNJ) the Best Dividend Paying Stock According to Hedge Funds? We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best dividend-paying stocks. Dividend-paying stocks have consistently attracted investor interest due to their long-term value. CNBC highlights this by examining […]",2025,4,14,0,446,70,83,14
"JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp have been highlighted in this Earnings Preview article.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp have been highlighted in this Earnings Preview article.'}",4fcb89cd-90a8-3954-bd96-98cc6122cb96,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/jpmorgan-wells-fargo-morgan-stanley-072200566.html?.tsrc=rss'}]",https://finance.yahoo.com/news/jpmorgan-wells-fargo-morgan-stanley-072200566.html?.tsrc=rss,2025-04-14 07:22:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=14, tm_hour=7, tm_min=22, tm_sec=0, tm_wday=0, tm_yday=104, tm_isdst=0)","JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview'}",JNJ,Yahoo Finance,"JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp have been highlighted in this Earnings Preview article.",2025,4,14,0,284,40,131,19
Novartis (NVS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.,"{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': ""Novartis (NVS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.""}",28a8f849-176f-30f9-ac2c-805294474432,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/novartis-nvs-surges-4-0-063000831.html?.tsrc=rss'}]",https://finance.yahoo.com/news/novartis-nvs-surges-4-0-063000831.html?.tsrc=rss,2025-04-14 06:30:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=14, tm_hour=6, tm_min=30, tm_sec=0, tm_wday=0, tm_yday=104, tm_isdst=0)",Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?'}",JNJ,Yahoo Finance,Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains? Novartis (NVS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.,2025,4,14,0,270,42,67,11
"We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best medical stocks to buy according to billionaires. Why are Healthcare Stocks Under Pressure? Some experts view medical, healthcare, and big […]","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best medical stocks to buy according to billionaires. Why are Healthcare Stocks Under Pressure? Some experts view medical, healthcare, and big […]'}",a003740d-019d-3fe1-83ae-1db23c932e26,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/why-johnson-johnson-jnj-best-214127916.html?.tsrc=rss'}]",https://finance.yahoo.com/news/why-johnson-johnson-jnj-best-214127916.html?.tsrc=rss,2025-04-13 21:41:27,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=13, tm_hour=21, tm_min=41, tm_sec=27, tm_wday=6, tm_yday=103, tm_isdst=0)",Why Johnson & Johnson (JNJ) is the Best Medical Stock to Buy According to Billionaires,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Why Johnson & Johnson (JNJ) is the Best Medical Stock to Buy According to Billionaires'}",JNJ,Yahoo Finance,"Why Johnson & Johnson (JNJ) is the Best Medical Stock to Buy According to Billionaires We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best medical stocks to buy according to billionaires. Why are Healthcare Stocks Under Pressure? Some experts view medical, healthcare, and big […]",2025,4,13,6,426,71,86,15
"We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other cheap NYSE stocks. On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends […]","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other cheap NYSE stocks. On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends […]'}",cab8f54b-9923-3a4d-9cc1-1733d9ba0213,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/johnson-johnson-nyse-jnj-cheap-130522494.html?.tsrc=rss'}]",https://finance.yahoo.com/news/johnson-johnson-nyse-jnj-cheap-130522494.html?.tsrc=rss,2025-04-12 13:05:22,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=12, tm_hour=13, tm_min=5, tm_sec=22, tm_wday=5, tm_yday=102, tm_isdst=0)",Is Johnson & Johnson (NYSE:JNJ) a Cheap NYSE Stock to Invest in According to Hedge Funds?,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Is Johnson & Johnson (NYSE:JNJ) a Cheap NYSE Stock to Invest in According to Hedge Funds?'}",JNJ,Yahoo Finance,"Is Johnson & Johnson (NYSE:JNJ) a Cheap NYSE Stock to Invest in According to Hedge Funds? We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other cheap NYSE stocks. On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends […]",2025,4,12,5,405,72,89,16
"We recently published a list of Jim Cramer Questions Market Logic and Dissects These 7 Key Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discusses. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer unpacked the deepening uncertainty […]","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'We recently published a list of Jim Cramer Questions Market Logic and Dissects These 7 Key Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discusses. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer unpacked the deepening uncertainty […]'}",e66f4567-1cb7-3894-b8f8-71082691e388,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/jim-cramer-johnson-johnson-jnj-175902159.html?.tsrc=rss'}]",https://finance.yahoo.com/news/jim-cramer-johnson-johnson-jnj-175902159.html?.tsrc=rss,2025-04-11 17:59:02,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=11, tm_hour=17, tm_min=59, tm_sec=2, tm_wday=4, tm_yday=101, tm_isdst=0)",Jim Cramer on Johnson & Johnson (JNJ): AAA Balance Sheet… An Unjustified Casualty of Pharma Tariffs,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Jim Cramer on Johnson & Johnson (JNJ): AAA Balance Sheet… An Unjustified Casualty of Pharma Tariffs'}",JNJ,Yahoo Finance,"Jim Cramer on Johnson & Johnson (JNJ): AAA Balance Sheet… An Unjustified Casualty of Pharma Tariffs We recently published a list of Jim Cramer Questions Market Logic and Dissects These 7 Key Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discusses. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer unpacked the deepening uncertainty […]",2025,4,11,4,443,74,99,16
JNJ's Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Tremfya. We do not expect any improvement in MedTech sales.,"{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': ""JNJ's Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Tremfya. We do not expect any improvement in MedTech sales.""}",6c70e023-4fd8-3b8c-9b4f-576138b88c8c,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/buy-sell-hold-j-j-153200724.html?.tsrc=rss'}]",https://finance.yahoo.com/news/buy-sell-hold-j-j-153200724.html?.tsrc=rss,2025-04-11 15:32:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=11, tm_hour=15, tm_min=32, tm_sec=0, tm_wday=4, tm_yday=101, tm_isdst=0)","Buy, Sell or Hold J&J Stock? Key Tips Ahead of Q1 Earnings","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Buy, Sell or Hold J&J Stock? Key Tips Ahead of Q1 Earnings'}",JNJ,Yahoo Finance,"Buy, Sell or Hold J&J Stock? Key Tips Ahead of Q1 Earnings JNJ's Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Tremfya. We do not expect any improvement in MedTech sales.",2025,4,11,4,216,38,58,12
Earnings preview of key companies reporting this week and what to look out for.,"{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Earnings preview of key companies reporting this week and what to look out for.'}",63b4a4b0-03c0-47f5-8c77-924188fd222e,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://uk.finance.yahoo.com/news/goldman-sachs-tsmc-asml-netflix-lvmh-and-sainsburys-stocks-to-watch-131111514.html?.tsrc=rss'}]",https://uk.finance.yahoo.com/news/goldman-sachs-tsmc-asml-netflix-lvmh-and-sainsburys-stocks-to-watch-131111514.html?.tsrc=rss,2025-04-11 13:11:11,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=11, tm_hour=13, tm_min=11, tm_sec=11, tm_wday=4, tm_yday=101, tm_isdst=0)","Stocks to watch this week: Goldman Sachs, TSMC, ASML, Netflix, LVMH and Sainsbury's","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': ""Stocks to watch this week: Goldman Sachs, TSMC, ASML, Netflix, LVMH and Sainsbury's""}",JNJ,Yahoo Finance,"Stocks to watch this week: Goldman Sachs, TSMC, ASML, Netflix, LVMH and Sainsbury's Earnings preview of key companies reporting this week and what to look out for.",2025,4,11,4,163,27,83,13
"The safety profile of icotrokinra was demonstrated to be 'favourable', according to the company.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': ""The safety profile of icotrokinra was demonstrated to be 'favourable', according to the company.""}",c73546e9-3901-3b54-a82d-945b52d20ad2,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://www.clinicaltrialsarena.com/news/jj-icotrokinra-psoriasis/?.tsrc=rss'}]",https://www.clinicaltrialsarena.com/news/jj-icotrokinra-psoriasis/?.tsrc=rss,2025-04-11 11:41:55,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=11, tm_hour=11, tm_min=41, tm_sec=55, tm_wday=4, tm_yday=101, tm_isdst=0)",J&J reports analysis from Phase III trial of plaque psoriasis treatment,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'J&J reports analysis from Phase III trial of plaque psoriasis treatment'}",JNJ,Yahoo Finance,"J&J reports analysis from Phase III trial of plaque psoriasis treatment The safety profile of icotrokinra was demonstrated to be 'favourable', according to the company.",2025,4,11,4,168,25,71,11
"Microsoft (NASDAQ: MSFT) and Johnson & Johnson (NYSE: JNJ) are leading companies in their respective industries.  Microsoft's market cap is $2.6 trillion, so some detractors feel it has little room to grow.  Meanwhile, Johnson & Johnson is still dealing with thousands of talc-related lawsuits, and recently hit another road bump in that department.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': ""Microsoft (NASDAQ: MSFT) and Johnson & Johnson (NYSE: JNJ) are leading companies in their respective industries.  Microsoft's market cap is $2.6 trillion, so some detractors feel it has little room to grow.  Meanwhile, Johnson & Johnson is still dealing with thousands of talc-related lawsuits, and recently hit another road bump in that department.""}",a03b0266-2381-35b9-8681-f1fed3edcc56,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://www.fool.com/investing/2025/04/11/2-top-dividend-stocks-to-buy-right-now/?source=eptyholnk0000202&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=0b724b3a-e8ff-42d6-82a8-cfbb88f82d2b&.tsrc=rss'}]",https://www.fool.com/investing/2025/04/11/2-top-dividend-stocks-to-buy-right-now/?source=eptyholnk0000202&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=0b724b3a-e8ff-42d6-82a8-cfbb88f82d2b&.tsrc=rss,2025-04-11 08:25:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=11, tm_hour=8, tm_min=25, tm_sec=0, tm_wday=4, tm_yday=101, tm_isdst=0)",2 Top Dividend Stocks to Buy Right Now,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': '2 Top Dividend Stocks to Buy Right Now'}",JNJ,Yahoo Finance,"2 Top Dividend Stocks to Buy Right Now Microsoft (NASDAQ: MSFT) and Johnson & Johnson (NYSE: JNJ) are leading companies in their respective industries.  Microsoft's market cap is $2.6 trillion, so some detractors feel it has little room to grow.  Meanwhile, Johnson & Johnson is still dealing with thousands of talc-related lawsuits, and recently hit another road bump in that department.",2025,4,11,4,388,61,38,8
Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.,"{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': ""Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.""}",5788e167-ba2e-3f2d-8e9e-4bfb72e0e2c1,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/m/5788e167-ba2e-3f2d-8e9e-4bfb72e0e2c1/s%26p%2C-dow-jones-pharma-names.html?.tsrc=rss'}]",https://finance.yahoo.com/m/5788e167-ba2e-3f2d-8e9e-4bfb72e0e2c1/s%26p%2C-dow-jones-pharma-names.html?.tsrc=rss,2025-04-10 16:58:23,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=10, tm_hour=16, tm_min=58, tm_sec=23, tm_wday=3, tm_yday=100, tm_isdst=0)","S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': ""S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash""}",JNJ,Yahoo Finance,"S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.",2025,4,10,3,215,32,73,13
"Evaluate the expected performance of Johnson & Johnson (JNJ) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Evaluate the expected performance of Johnson & Johnson (JNJ) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.'}",597d79bb-14b2-3483-ad21-cd6600245366,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/seeking-clues-johnson-johnson-jnj-131512923.html?.tsrc=rss'}]",https://finance.yahoo.com/news/seeking-clues-johnson-johnson-jnj-131512923.html?.tsrc=rss,2025-04-10 13:15:12,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=10, tm_hour=13, tm_min=15, tm_sec=12, tm_wday=3, tm_yday=100, tm_isdst=0)",Seeking Clues to Johnson & Johnson (JNJ) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Seeking Clues to Johnson & Johnson (JNJ) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics'}",JNJ,Yahoo Finance,"Seeking Clues to Johnson & Johnson (JNJ) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics Evaluate the expected performance of Johnson & Johnson (JNJ) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",2025,4,10,3,332,51,105,18
"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.'}",f515e359-5d6b-37af-8c12-92cd66252e73,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/johnson-johnson-jnj-trending-stock-130015450.html?.tsrc=rss'}]",https://finance.yahoo.com/news/johnson-johnson-jnj-trending-stock-130015450.html?.tsrc=rss,2025-04-10 13:00:15,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=10, tm_hour=13, tm_min=0, tm_sec=15, tm_wday=3, tm_yday=100, tm_isdst=0)",Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It'}",JNJ,Yahoo Finance,"Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",2025,4,10,3,227,42,79,15
"We recently published a list of Jim Cramer Says Tariff Pain Isn’t Over Yet And Reviews These 9 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discusses. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer dissected […]","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'We recently published a list of Jim Cramer Says Tariff Pain Isn’t Over Yet And Reviews These 9 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discusses. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer dissected […]'}",e3f04ed2-2700-32a4-a768-e58ea75b9b69,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/jim-cramer-johnson-johnson-jnj-124243597.html?.tsrc=rss'}]",https://finance.yahoo.com/news/jim-cramer-johnson-johnson-jnj-124243597.html?.tsrc=rss,2025-04-10 12:42:43,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=10, tm_hour=12, tm_min=42, tm_sec=43, tm_wday=3, tm_yday=100, tm_isdst=0)",Jim Cramer’s Take On Johnson & Johnson (JNJ): Are Litigation Fears Creating a Rare Buying Opportunity?,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Jim Cramer’s Take On Johnson & Johnson (JNJ): Are Litigation Fears Creating a Rare Buying Opportunity?'}",JNJ,Yahoo Finance,"Jim Cramer’s Take On Johnson & Johnson (JNJ): Are Litigation Fears Creating a Rare Buying Opportunity? We recently published a list of Jim Cramer Says Tariff Pain Isn’t Over Yet And Reviews These 9 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discusses. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer dissected […]",2025,4,10,3,425,73,102,16
"Johnson & Johnson (NYSE: JNJ) today announced new icotrokinra (JNJ-2113) data from a subgroup analysis of ICONIC-LEADa, the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis (PsO) to assess efficacy and safety of a systemic therapy in adolescents and adults simultaneously. These data, presented at the 2025 World Congress of Pediatric Dermatology (WCPD) Annual Meeting, show adolescents treated with once daily icotrokinra achieved higher rates of clear or almost clear","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Johnson & Johnson (NYSE: JNJ) today announced new icotrokinra (JNJ-2113) data from a subgroup analysis of ICONIC-LEADa, the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis (PsO) to assess efficacy and safety of a systemic therapy in adolescents and adults simultaneously. These data, presented at the 2025 World Congress of Pediatric Dermatology (WCPD) Annual Meeting, show adolescents treated with once daily icotrokinra achieved higher rates of clear or almost clear'}",aea56fed-6fdc-33fa-9c9d-d3cabe7242ea,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/icotrokinra-results-show-75-adolescents-120500105.html?.tsrc=rss'}]",https://finance.yahoo.com/news/icotrokinra-results-show-75-adolescents-120500105.html?.tsrc=rss,2025-04-10 12:05:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=10, tm_hour=12, tm_min=5, tm_sec=0, tm_wday=3, tm_yday=100, tm_isdst=0)",Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=JNJ&region=US&lang=en-US', 'value': 'Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill'}",JNJ,Yahoo Finance,"Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill Johnson & Johnson (NYSE: JNJ) today announced new icotrokinra (JNJ-2113) data from a subgroup analysis of ICONIC-LEADa, the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis (PsO) to assess efficacy and safety of a systemic therapy in adolescents and adults simultaneously. These data, presented at the 2025 World Congress of Pediatric Dermatology (WCPD) Annual Meeting, show adolescents treated with once daily icotrokinra achieved higher rates of clear or almost clear",2025,4,10,3,658,95,158,23
